Thoracoscopic Resection of a Nonseminomatous Primary Mediastinal Germ Cell Tumor.

MedStar author(s):
Citation: Seminars in Thoracic & Cardiovascular Surgery. 31(4):870-872, 2019 Winter.PMID: 30981738Institution: MedStar Washington Hospital CenterDepartment: Surgery/Thoracic SurgeryForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Mediastinal Neoplasms/su [Surgery] | *Neoplasms, Germ Cell and Embryonal/su [Surgery] | *Testicular Neoplasms/su [Surgery] | *Thoracic Surgery, Video-Assisted | Adult | Chemotherapy, Adjuvant | Humans | Male | Mediastinal Neoplasms/dg [Diagnostic Imaging] | Mediastinal Neoplasms/pa [Pathology] | Neoadjuvant Therapy | Neoplasms, Germ Cell and Embryonal/dg [Diagnostic Imaging] | Neoplasms, Germ Cell and Embryonal/pa [Pathology] | Testicular Neoplasms/dg [Diagnostic Imaging] | Testicular Neoplasms/pa [Pathology] | Treatment OutcomeYear: 2019ISSN:
  • 1043-0679
Name of journal: Seminars in thoracic and cardiovascular surgeryAbstract: Copyright (c) 2019 Elsevier Inc. All rights reserved.PMNGCT is an independent predictor of poor prognosis despite advances in multidisciplinary management. Multidrug chemotherapy followed by aggressive surgical resection remains the mainstay of treatment. Although associated with significant morbidity, an open surgical approach is traditionally used. We describe the first reported case, to our knowledge, of a patient who underwent resection of a PMNGCT via a minimally invasive approach following induction chemotherapy.All authors: Caso R, Marshall MBOriginally published: Seminars in Thoracic & Cardiovascular Surgery. 2019 Apr 11Fiscal year: FY2020Fiscal year of original publication: FY2019Digital Object Identifier: Date added to catalog: 2019-05-21
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 30981738 Available 30981738

Copyright (c) 2019 Elsevier Inc. All rights reserved.

PMNGCT is an independent predictor of poor prognosis despite advances in multidisciplinary management. Multidrug chemotherapy followed by aggressive surgical resection remains the mainstay of treatment. Although associated with significant morbidity, an open surgical approach is traditionally used. We describe the first reported case, to our knowledge, of a patient who underwent resection of a PMNGCT via a minimally invasive approach following induction chemotherapy.

English

Powered by Koha